PRO DEX vs Sight Sciences
PRO DEX and Sight Sciences are similar in size: $77.5m and $77.4m of revenue in their latest fiscal years. PRO DEX grew faster (16.5% against -3.1%). PRO DEX kept more of each dollar of sales as profit: a net margin of 17.6% against -49.7%. PRO DEX carries less debt relative to equity (45.6% against 66.3%).
| Latest fiscal year | PRO DEXPDEX, 2026 | Sight SciencesSGHT, 2025 |
|---|---|---|
| Revenue | $77.5m | $77.4m |
| Revenue growth | 16.5% | -3.1% |
| Net income | $13.7m | −$38.4m |
| Operating margin | 16.8% | -48.0% |
| Net margin | 17.6% | -49.7% |
| Return on equity | 32.4% | -50.7% |
| Free cash flow | $6.8m | −$29.9m |
| Cash | $8.2m | $92.0m |
| Total debt | $21.7m | $42.4m |
| Debt to equity | 45.6% | 66.3% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $3.4m | — |
| Employees | 206 | 186 |
| Market value | $192m | $516m |
| Price vs our value range | Above our value range | — |
| Moat score | 70 (Strong) | 35 (Weak) |
| Insider trades, 12 months | 0 buys, 20 sales | 2 buys, 38 sales |